Concepedia

Yuan Xu

YX

28

Publications

1.4K

Citations

18

H-Index

2012

Active since

Affiliations

United States Food and Drug Administration(Current)

Fujian Medical University

Beijing Chao-Yang Hospital

Center for Drug Evaluation and Research

China-Japan Friendship Hospital

Yuan Xu is an author at United States Food and Drug Administration specializing in engineering, chemical engineering, and health sciences.

ORCID

Top concepts

Publications per year

2012–2024

28

Publications

28

Association of Time‐Varying Clearance of Nivolumab With Disease Dynamics and Its Implications on Exposure Response Analysis

C Liu, Jiajie Yu, H Li et al. · Clinical Pharmacology & Therapeutics · 2017 · 184 citations

FDA Approval Summary: Atezolizumab Plus Bevacizumab for the Treatment of Patients with Advanced Unresectable or Metastatic Hepatocellular Carcinoma

Sandra J. Casak, Martha Donoghue, Lola A. Fashoyin‐Aje et al. · Clinical Cancer Research · 2020 · 170 citations

FDA Approval Summary: Atezolizumab Plus Paclitaxel Protein-bound for the Treatment of Patients with Advanced or Metastatic TNBC Whose Tumors Express PD-L1

Preeti Narayan, Sakar Wahby, Jennifer Gao et al. · Clinical Cancer Research · 2020 · 164 citations

, , +17

Short-term anti-vascular endothelial growth factor treatment elicits vasculogenic mimicry formation of tumors to accelerate metastasis

Yuan Xu, Qin Li, Xiaoyu Li et al. · Journal of Experimental & Clinical Cancer Research · 2012 · 153 citations · Full text

Exenatide improves type 2 diabetes concomitant with non-alcoholic fatty liver disease

Hui Fan, Qingrong Pan, Yuan Xu et al. · Arquivos Brasileiros de Endocrinologia & Metabologia · 2013 · 116 citations · Full text

Rows per page

1–5 of 28